Most frequent somatic mutations involved TP53 (N = 15, all HGSC), followed by ARID1A (N = 2, all clear cell cancer), and PIK3CA (N = 2, one clear cell and one endometrioid carcinoma). This evidence concerns the gene PIK3CA and endometrioid adenocarcinoma.